Literature DB >> 20098081

Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies.

Hyun Sun Park1, Jung Won Choi, Byoung-kwon Kim, Kwang Hyun Cho.   

Abstract

Lupus erythematosus panniculitis (LEP) is an inflammatory disorder of the subcutaneous fat in patients with lupus erythematosus (LE). It is a rare variant of the disease, which occurs approximately in 1%-3% of patients with cutaneous LE. The purpose of this study was to investigate the clinical, histopathologic, immunophenotypical, and molecular profiles of LEP. We performed a retrospective study of 19 biopsy specimens from 17 patients with LEP. We reviewed their clinical data and reexamined the histopathology. Immunophenotyping and molecular studies were done using sections from paraffin-embedded formalin-fixed tissue. The most common clinical manifestation was a depressed patch on upper arm. Patients showed good response to variable treatment modalities, but, generally, relapse of panniculitis was noted when treatment was discontinued. Histopathologically, most specimens revealed lymphoplasmacytic lobular panniculitis with epidermal and dermal changes of LE, hyaline fat necrosis, and lymphoid follicles. Immunohistochemistry showed a mixture of T and B cells in dermis and subcutis with a slight preponderance of T cell. Although the polymerase chain reaction analysis of the T-cell receptor-gamma gene rearrangement showed a polyclonal smear in 89.5% of cases, a small portion of specimens demonstrated monoclonality. LEP is a chronic recurrent disease with characteristic features. Its diagnosis is often challenging, and a precise diagnosis is achievable only upon elaborate clinicopathologic correlation and integrated interpretation of all diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098081     DOI: 10.1097/DAD.0b013e3181b4a5ec

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

Review 1.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 2.  [Differential diagnosis of panniculitides].

Authors:  A Böer-Auer
Journal:  Hautarzt       Date:  2016-07       Impact factor: 0.751

Review 3.  Lupus Panniculitis as an Initial Manifestation of Systemic Lupus Erythematosus: A Case Report.

Authors:  Yu-Kun Zhao; Fang Wang; Wen-Na Chen; Rui Xu; Zhuo Wang; Yuan-Wen Jiang; Di-Qing Luo; Jian-De Han
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Purulent lupus panniculitis unmasked by FDG-PET/CT scan: A case report.

Authors:  Kornelis S M van der Geest; Rada V Moerman; Klaas P Koopmans; Nicole D Holman; Wilbert M T Janssen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Lymphocytic Lobular Panniculitis: A Diagnostic Challenge.

Authors:  Silvia Alberti-Violetti; Emilio Berti
Journal:  Dermatopathology (Basel)       Date:  2018-02-15

6.  Lupus Profundus: A Case Report from Pakistan.

Authors:  Amber Siddiqui; Haseeb A Bhatti; Javeria Ashfaq
Journal:  Cureus       Date:  2018-05-28

7.  Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis.

Authors:  Nada G AlQadri; Bayan AlNooh; Malak M AlTewerki; Ahmad Almotairi; Saad Alajlan
Journal:  Cureus       Date:  2020-01-27

8.  A rare case of suspected lupus erythematous panniculitis as the presenting skin feature of juvenile dermatomyositis: A case report.

Authors:  Dylan C Ginter; Michele L Ramien; Marie-Anne Brundler; Laura C Swaney; Paivi Mh Miettunen; Nadia Jc Luca
Journal:  SAGE Open Med Case Rep       Date:  2022-03-25

9.  Elevated apoptosis and impaired proliferation contribute to downregulated peripheral γ δ T cells in patients with systemic lupus erythematosus.

Authors:  Zhimin Lu; Dinglei Su; Dandan Wang; Xia Li; Xuebing Feng; Lingyun Sun
Journal:  Clin Dev Immunol       Date:  2013-08-25

10.  Cytophagic histiocytic panniculitis, hemophagocytic lymphohistiocytosis and undetermined autoimmune disorder: reconciling the puzzle.

Authors:  Claudia Pasqualini; Mauro Jorini; Ines Carloni; Mirella Giangiacomi; Valentina Cetica; Maurizio Aricò; Fernando Maria de Benedictis
Journal:  Ital J Pediatr       Date:  2014-02-13       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.